Envision Healthcare (NYSE:EVHC) has been given a $46.00 price target by investment analysts at Jefferies Group in a note issued to investors on Thursday. The brokerage presently has a “buy” rating on the stock. Jefferies Group’s price target points to a potential upside of 17.92% from the stock’s current price.
Other research analysts have also recently issued research reports about the company. Stephens reiterated a “hold” rating and issued a $34.00 target price on shares of Envision Healthcare in a report on Wednesday, January 10th. ValuEngine cut Envision Healthcare from a “buy” rating to a “hold” rating in a research note on Friday, February 2nd. Canaccord Genuity restated a “buy” rating and set a $46.00 price objective (up previously from $32.00) on shares of Envision Healthcare in a research note on Wednesday, February 28th. Robert W. Baird set a $45.00 price objective on Envision Healthcare and gave the stock a “buy” rating in a research note on Monday, February 26th. Finally, Zacks Investment Research upgraded Envision Healthcare from a “strong sell” rating to a “hold” rating in a research note on Tuesday, January 2nd. One analyst has rated the stock with a sell rating, eight have assigned a hold rating and nine have issued a buy rating to the company. Envision Healthcare has a consensus rating of “Hold” and an average target price of $42.57.
Envision Healthcare (EVHC) opened at $39.01 on Thursday. Envision Healthcare has a fifty-two week low of $23.77 and a fifty-two week high of $66.39. The firm has a market capitalization of $4,823.70, a price-to-earnings ratio of -18.85, a P/E/G ratio of 1.00 and a beta of 0.48. The company has a debt-to-equity ratio of 0.87, a current ratio of 3.40 and a quick ratio of 3.38.
Envision Healthcare (NYSE:EVHC) last issued its earnings results on Tuesday, February 27th. The company reported $0.59 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.45 by $0.14. Envision Healthcare had a positive return on equity of 4.62% and a negative net margin of 2.52%. The firm had revenue of $2 billion for the quarter, compared to analysts’ expectations of $1.97 billion. During the same quarter last year, the firm earned $1.15 earnings per share. The firm’s revenue for the quarter was up 68.0% compared to the same quarter last year. equities analysts forecast that Envision Healthcare will post 3.34 EPS for the current fiscal year.
Several hedge funds and other institutional investors have recently made changes to their positions in EVHC. CIBC World Markets Inc. purchased a new stake in shares of Envision Healthcare during the fourth quarter worth about $208,000. OLD Mutual Customised Solutions Proprietary Ltd. increased its position in shares of Envision Healthcare by 88.2% during the fourth quarter. OLD Mutual Customised Solutions Proprietary Ltd. now owns 6,401 shares of the company’s stock worth $221,000 after acquiring an additional 3,000 shares during the last quarter. CENTRAL TRUST Co increased its position in shares of Envision Healthcare by 79.7% during the fourth quarter. CENTRAL TRUST Co now owns 6,626 shares of the company’s stock worth $229,000 after acquiring an additional 2,939 shares during the last quarter. Alps Advisors Inc. purchased a new stake in shares of Envision Healthcare during the fourth quarter worth about $235,000. Finally, M&T Bank Corp increased its position in shares of Envision Healthcare by 33.6% during the fourth quarter. M&T Bank Corp now owns 6,818 shares of the company’s stock worth $235,000 after acquiring an additional 1,716 shares during the last quarter.
COPYRIGHT VIOLATION WARNING: This news story was originally reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this news story on another site, it was illegally copied and republished in violation of international trademark and copyright laws. The correct version of this news story can be read at https://www.dispatchtribunal.com/2018/03/17/envision-healthcare-evhc-pt-set-at-46-00-by-jefferies-group.html.
Envision Healthcare Company Profile
Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.
Receive News & Ratings for Envision Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.